30 results on '"Dunlap, Mark E."'
Search Results
2. Cardiopulmonary Baroreflex Control of Renal Sympathetic Nerve Activity Is Impaired in Dogs With Left Ventricular Dysfunction
3. “I've Had a Good Run”
4. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial
5. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group
6. Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)
7. In-Hospital Resource Use and Medical Costs in the Last Year of Life by Mode of Death (from the HF-ACTION Randomized Controlled Trial)
8. Incidence and Predictors of Hyperkalemia in Patients With Heart Failure: An Analysis of the CHARM Program
9. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
10. Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies
11. Reconsidering Renal Sympathetic Denervation for Heart Failure
12. Measuring Congestion in Acute Heart Failure: The “Holy Grail” Still Awaits
13. The Heart Failure Clinic: A Consensus Statement of the Heart Failure Society of America
14. Patients With HF Show High Degrees of Moderate to Severe Cognitive Impairment Despite Normal MMSE Testing
15. Hospital Management of Hyponatremia in Patients with Heart Failure: Final Report from the HN Registry
16. Heart Failure Notwithstanding Ejection Fraction (HFnEF)—A Possible Unifying Hypothesis?
17. Target Doses of Cardioprotective Agents Reduce Risk of Cardiovascular Hospitalization in HF Patients Compared to Lower Doses
18. Mode of Death in Contemporary Heart Failure Patients and the Impact of Structured Exercise: Insights from the HF-ACTION Trial
19. Fluid Re-Distribution Rather Than Accumulation Causes Most Cases of Decompensated Heart Failure
20. Doing the Right Thing
21. Denervation of vagal cardiopulmonary receptors by injection of kainic acid into the nodose ganglia in dogs
22. Resource Use and Medical Costs by Cause of Death in HF-ACTION
23. Optimal Heart Failure Management in the Outpatient Setting: Assessing Treatment by Provider Type
24. Vaccination Rates in Heart Failure: Are We Missing the Target?
25. Lack of Correlation between HF Performance Measures and 30-Day Rehospitalization Rates
26. Augmentation index and central aortic stiffness in middle-aged and older persons
27. Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials
28. Treatment with enalapril fails to prevent impaired cardiopulmonary baroreflex control in dogs with left ventricular dysfunction
29. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure
30. A Simplified Technique for the Production of Heart Failure in the Dog by Rapid Ventricular Pacing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.